Ensign Group Securities Class Action (ENSG) — Investors Sue Over Nursing-Home Care and Billing Claims
PublishedOctober 9, 2026
Investors who bought Ensign Group stock between February 10, 2022 and June 18, 2026 may be covered by a proposed securities class action alleging the nursing-home operator hid care, staffing and billing problems that two short-seller reports later described. No class has been certified and there is nothing to file yet.
This article describes a class action complaint and the short-seller reports it relies on. The
statements below are unproven allegations. The Ensign Group, Barry R. Port and Suzanne D. Snapper
have not been found liable, there is no certified class, and nothing to claim at this time. This
page is informational and is not legal advice.
What Is This About?
An Ensign Group shareholder filed a proposed securities class action against the company on October 8, 2026, in the U.S. District Court for the Central District of California. Ensign, which is based in San Juan Capistrano, California, and trades on Nasdaq as ENSG, runs one of the country’s largest networks of skilled nursing and senior living facilities. The case is Perusek v. The Ensign Group, Inc., No. 8:26-cv-02963. Besides the company, the 66-page complaint names CEO Barry R. Port and CFO Suzanne D. Snapper. It alleges that for more than four years Ensign’s public filings and statements about care quality and regulatory risk left out problems with staffing, billing and resident care that two short-seller reports described in June 2026. The defendants have not yet responded in court.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
StatusComplaint FiledFiled October 8, 2026 · C.D. California · defendants have not yet responded
Class PeriodFebruary 10, 2022 – June 18, 2026Purchasers of publicly traded Ensign Group securities (Nasdaq: ENSG)
Lead Plaintiff DeadlineDecember 7, 2026Per the PSLRA notice from plaintiff’s counsel · optional, not required to stay in a class
Can I Claim?No — nothing to claim yetNo settlement, certified class or claim form
What Does the Lawsuit Allege?
Most of Ensign’s revenue comes from Medicare and Medicaid, which pay nursing facilities more to care for sicker residents and require them to keep enough nursing staff to meet residents’ needs. The complaint challenges risk disclosures in Ensign’s annual reports for 2021 through 2025, which described government audits, survey deficiencies and CMS star ratings as possible risks to the business. It also challenges an April 30, 2026 earnings release in which Port said Ensign’s same-store facilities outperformed their peers on CMS survey results and five-star quality measures.
The plaintiff says those statements were misleading because they left out conduct the complaint attributes to Ensign. According to the complaint, Ensign:
relied on understaffing and neglect of elderly residents, including those who needed high levels of care, to drive profits;
took Medicare and Medicaid payments meant for high-acuity residents without staffing to meet those residents’ needs;
used self-reported data to lift its facilities’ CMS star ratings, and recorded non-clinical workers’ hours as nursing-assistant hours;
listed licensed administrators at some facilities who were rarely present or managing them; and
understated the regulatory, reputational and litigation risk that came with these practices.
These are the plaintiff’s claims, drawn largely from the short-seller reports described below. No court or regulator has made findings on them in this case.
The Short-Seller Reports and Stock Drops
Securities suits have to tie investor losses to specific moments when the alleged truth reached the market. This complaint points to three publications in June 2026:
June 8, 2026 — Hunterbrook: Hunterbrook Media published “Ensign: The Nursing Home Empire Built on Fatal Neglect.” It said it tracked 161 facilities before and after Ensign acquired them and found nursing hours, especially registered-nurse hours, fell after acquisition while star ratings rose. It estimated a staffing gap of about 5 million nursing hours between July and November 2024, and cited residents, families and former staff describing neglect. Ensign stock fell $13.88, or 8.15%, to close at $156.42.
June 11, 2026 — Muddy Waters: Muddy Waters Research, which said it was short Ensign stock, published “Ensign: Deceiving the Government at Estimated ~20% of Facilities.” It said investigators visited 57 Ensign facilities in eight states and found signs at 12 of them that the licensed administrator on record was not running the facility day to day. The stock fell $4.52, or 2.98%, to close at $147.13.
June 18, 2026 — Hunterbrook follow-up: A second Hunterbrook article, “New: Patients Hungry in Ensign Facilities,” relayed accounts from current and former staff about food, supplies and how staff hours were logged. The stock fell $2.19, or 1.4%, to close at $153.65.
The figures above come from the complaint. Hunterbrook and Muddy Waters are investment-focused publishers, and Muddy Waters disclosed that it stood to profit from a falling share price. Whether the declines were caused by the alleged misstatements is a question the court has not reached.
What Has Ensign Said?
Ensign has not yet appeared in the case. The complaint says that as of June 23, 2026 the company had not published a public response to either report. The Orange County Business Journal reported on June 22, 2026 that Ensign declined to comment to it, but that, according to a UBS analyst note, Ensign expressed confidence in its practices and its roughly 20-year operating history. Ensign also disputed the staffing data behind the reports, noting that CMS has called it incomplete, and said only six of its 396 facilities had an administrator in transition. In mid-June the board expanded the company’s stock repurchase authorization to $100 million, and Port said the move “underscores our confidence in the strength, integrity and upside potential of our company.”
Who Is in the Proposed Class?
The complaint defines the class as everyone, other than the defendants, who bought or otherwise acquired publicly traded Ensign securities on Nasdaq between February 10, 2022 and June 18, 2026, inclusive, and was damaged. The company’s officers and directors, their immediate families and entities the defendants control are excluded. The suit brings two claims: one under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 against all three defendants, and one under Section 20(a), the “control person” provision, against Port and Snapper. It seeks damages with interest, costs and fees, and a jury trial. The plaintiff is represented by The Rosen Law Firm.
What Happens Next?
Under the Private Securities Litigation Reform Act, the notice published by the plaintiff’s counsel sets December 7, 2026 as the deadline for investors to ask the court to be appointed lead plaintiff — the investor, usually one with a large loss, who directs the case for the class. That step is optional. Under the law, an investor who does not seek lead-plaintiff status can still be part of any class the court later certifies, subject to the final class definition and any later claims process.
After the court appoints a lead plaintiff and lead counsel, an amended complaint is typically filed and the defendants usually move to dismiss. Securities class actions often take years, and many are dismissed; there is no guarantee of certification, settlement or recovery. There is no settlement and no claim form today. OCA will update this page as the case develops.
Read the Complaint
Questions
Who is covered by the Ensign Group securities class action?
The complaint proposes a class of everyone who bought or otherwise acquired publicly traded Ensign Group securities on Nasdaq between February 10, 2022 and June 18, 2026, inclusive, and was damaged. The defendants, the company’s officers and directors, their immediate families and related entities are excluded. No class has been certified.
What is the lead plaintiff deadline in the Ensign Group case?
The notice published by the plaintiff’s counsel under the Private Securities Litigation Reform Act lists December 7, 2026 as the deadline to ask the court to be appointed lead plaintiff. Seeking that role is optional. Under the law, investors who do not seek it can still be members of any class the court later certifies.
Is there an Ensign Group settlement or claim form?
No. The case was filed on October 8, 2026 and is at the complaint stage. There is no settlement, no certified class and no claim form. If the case ever settles, the court would approve a notice explaining any claim process and deadline.
What did the Hunterbrook and Muddy Waters reports say about Ensign?
Hunterbrook’s June 8, 2026 report alleged that nursing hours fall at facilities after Ensign acquires them while star ratings rise, and that residents were harmed by understaffing. Muddy Waters, which disclosed a short position, alleged on June 11, 2026 that an estimated 20% of Ensign facilities list licensed administrators who are rarely on site. Both reports are allegations; Ensign has disputed parts of them and none has been proven in court.
Who are the defendants in the Ensign Group stock lawsuit?
The defendants are The Ensign Group, Inc., CEO Barry R. Port and CFO Suzanne D. Snapper. None of them has been found liable, and they have not yet responded to the complaint in court.